179 related articles for article (PubMed ID: 14716513)
1. Carcinogenesis of gastric endocrine cell carcinoma: analysis of histopathology and p53 gene alteration.
Nishikura K; Watanabe H; Iwafuchi M; Fujiwara T; Kojima K; Ajioka Y
Gastric Cancer; 2003; 6(4):203-9. PubMed ID: 14716513
[TBL] [Abstract][Full Text] [Related]
2. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
[TBL] [Abstract][Full Text] [Related]
3. Mutations of p53 gene in gastric carcinoma in Taiwan.
Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
[TBL] [Abstract][Full Text] [Related]
4. Numerical aberration and point mutation of p53 gene in human gastric intestinal metaplasia and well-differentiated adenocarcinoma: analysis by fluorescence in situ hybridization (FISH) and PCR-SSCP.
Gomyo Y; Osaki M; Kaibara N; Ito H
Int J Cancer; 1996 May; 66(5):594-9. PubMed ID: 8647618
[TBL] [Abstract][Full Text] [Related]
5. p53 gene mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type.
Ranzani GN; Luinetti O; Padovan LS; Calistri D; Renault B; Burrel M; Amadori D; Fiocca R; Solcia E
Cancer Epidemiol Biomarkers Prev; 1995; 4(3):223-31. PubMed ID: 7606196
[TBL] [Abstract][Full Text] [Related]
6. Relationship between E-cadherin gene mutation and p53 gene mutation, p53 accumulation, Bcl-2 expression and Ki-67 staining in diffuse-type gastric carcinoma.
Fricke E; Keller G; Becker I; Rosivatz E; Schott C; Plaschke S; Rudelius M; Hermannstädter C; Busch R; Höfler H; Becker KF; Luber B
Int J Cancer; 2003 Mar; 104(1):60-5. PubMed ID: 12532420
[TBL] [Abstract][Full Text] [Related]
7. p53 mutation profiling of multiple esophageal carcinoma using laser capture microdissection to demonstrate field carcinogenesis.
Ito S; Ohga T; Saeki H; Nakamura T; Watanabe M; Tanaka S; Kakeji Y; Maehara Y
Int J Cancer; 2005 Jan; 113(1):22-8. PubMed ID: 15386362
[TBL] [Abstract][Full Text] [Related]
8. Combined small-cell carcinoma of the stomach: p53 and K-ras gene mutational analysis supports a monoclonal origin of three histological components.
Han B; Mori I; Wang X; Nakamura M; Nakamura Y; Kakudo K
Int J Exp Pathol; 2005 Aug; 86(4):213-8. PubMed ID: 16045543
[TBL] [Abstract][Full Text] [Related]
9. Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract.
Pizzi S; Azzoni C; Bassi D; Bottarelli L; Milione M; Bordi C
Cancer; 2003 Sep; 98(6):1273-82. PubMed ID: 12973852
[TBL] [Abstract][Full Text] [Related]
10. Genetic evidence for the multicentric origin of synchronous multiple gastric carcinoma.
Kang GH; Kim CJ; Kim WH; Kang YK; Kim HO; Kim YI
Lab Invest; 1997 Mar; 76(3):407-17. PubMed ID: 9121123
[TBL] [Abstract][Full Text] [Related]
11. [Mutations of the p53 suppressor gene in gastric adenocarcinoma].
Aranda M; Náquira N; Karque R; Mendoza H; Sepúlveda C; Silva C
Rev Med Chil; 1998 May; 126(5):525-32. PubMed ID: 9731434
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of p53 mutational status in the superficial spreading type of early gastric carcinoma.
Iwamatsu H; Nishikura K; Watanabe H; Ajioka Y; Hashidate H; Kashimura H; Asakura H
Gastric Cancer; 2001; 4(1):20-6. PubMed ID: 11706623
[TBL] [Abstract][Full Text] [Related]
13. Hybrid carcinomas of the salivary glands: report of nine cases with a clinicopathologic, immunohistochemical, and p53 gene alteration analysis.
Nagao T; Sugano I; Ishida Y; Asoh A; Munakata S; Yamazaki K; Konno A; Iwaya K; Shimizu T; Serizawa H; Ebihara Y
Mod Pathol; 2002 Jul; 15(7):724-33. PubMed ID: 12118110
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of p53 is associated with growth pattern and prognosis in advanced gastric cancer.
Ichiyoshi Y; Oiwa H; Tomisaki S; Sakaguchi Y; Ohno S; Maehara Y; Sugimachi K
Hepatogastroenterology; 1997; 44(14):546-53. PubMed ID: 9164535
[TBL] [Abstract][Full Text] [Related]
15. p53 protein overexpression and allele loss of p53 gene in gastric adenocarcinoma.
Choi SW; Park WS; Yang JM; Kang CS; Sun HS; Kim BS; Seo EJ; Lee MJ; Park CS
J Korean Med Sci; 1994 Aug; 9(4):299-303. PubMed ID: 7848577
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of p53 predicts shorter survival in diffuse type gastric cancer.
Lee WJ; Shun CT; Hong RL; Wu MS; Chang KJ; Chen KM
Br J Surg; 1998 Aug; 85(8):1138-42. PubMed ID: 9718015
[TBL] [Abstract][Full Text] [Related]
17. Multiple early gastric carcinomas. Clinicopathologic features and histogenesis.
Isozaki H; Okajima K; Hu X; Fujii K; Sako S
Cancer; 1996 Nov; 78(10):2078-86. PubMed ID: 8918400
[TBL] [Abstract][Full Text] [Related]
18. [Expression of p53 in gastric carcinoma. Prognostic value].
Sundblad A; Pellicer EM; Mehta P; Ahn C; Battifora H
Medicina (B Aires); 1994; 54(3):216-20. PubMed ID: 7854087
[TBL] [Abstract][Full Text] [Related]
19. [p53 gene deletion and abnormal expression in gastric carcinoma].
Yang D; Li T; Xu W
Zhonghua Zhong Liu Za Zhi; 1995 May; 17(3):175-8. PubMed ID: 7656819
[TBL] [Abstract][Full Text] [Related]
20. Low presence of p53 abnormalities in H pylori-infected gastric mucosa and in gastric adenocarcinoma.
Berloco P; Russo F; Cariola F; Gentile M; Giorgio P; Caruso ML; Valentini AM; Di Matteo G; Di Leo A
J Gastroenterol; 2003; 38(1):28-36. PubMed ID: 12560919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
